1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Compliance: new trials by email Literature Review of Compliance trials Research Report on Compliance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain acetazolamide, Quinine, Riboflavin - Compliance, Chronic Pain | Phase 2 | Withdrawn | Georgetown University | 2014-12-01 | 2017-02-10 |
Chronic Pain (1) · Narcotic-Related Disorders (1) · Opioid-Related Disorders (1) · Patient Compliance (1)
Behavior (1) · Chemically-Induced Disorders (1) · Health Behavior (1) · Mental Disorders (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Patient Acceptance of Health Care (1) · Signs and Symptoms (1) · Substance-Related Disorders (1) · Treatment Adherence and Compliance (1)
Acetazolamide (1) · Quinine (1) · Riboflavin (1)
United States (1)